These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 19566786

  • 1. Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
    Ohki T, Tateishi R, Goto E, Sato T, Masuzaki R, Imamura J, Goto T, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M.
    J Viral Hepat; 2010 Feb 01; 17(2):91-7. PubMed ID: 19566786
    [Abstract] [Full Text] [Related]

  • 2. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 3. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M.
    Int J Mol Med; 2006 May 01; 17(5):827-32. PubMed ID: 16596267
    [Abstract] [Full Text] [Related]

  • 4. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 5. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 15; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 6. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF).
    Am J Gastroenterol; 2008 Aug 15; 103(8):1966-72. PubMed ID: 18637087
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan 15; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 8. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jan 15; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M.
    Clin Gastroenterol Hepatol; 2006 Aug 15; 4(8):1062-8. PubMed ID: 16844421
    [Abstract] [Full Text] [Related]

  • 10. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May 15; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 11. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Jun 15; 20(6):850-6. PubMed ID: 15946131
    [Abstract] [Full Text] [Related]

  • 12. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 13. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G.
    Cancer; 2000 Jul 01; 89(1):53-9. PubMed ID: 10897000
    [Abstract] [Full Text] [Related]

  • 14. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis.
    Sagnelli E, Pasquale G, Coppola N, Marrocco C, Scarano F, Imparato M, Sagnelli C, Scolastico C, Piccinino F.
    J Med Virol; 2005 Feb 01; 75(2):222-6. PubMed ID: 15602732
    [Abstract] [Full Text] [Related]

  • 15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul 01; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 16. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 01; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 17. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M.
    Clin Gastroenterol Hepatol; 2008 Apr 01; 6(4):459-64. PubMed ID: 18387499
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K.
    Am J Gastroenterol; 1993 Jan 01; 88(1):39-43. PubMed ID: 7678368
    [Abstract] [Full Text] [Related]

  • 19. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, Koga M, Nakata K, Eguchi K, Yano M.
    Cancer; 2002 Jul 15; 95(2):331-9. PubMed ID: 12124834
    [Abstract] [Full Text] [Related]

  • 20. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M.
    Intervirology; 2008 Jul 15; 51(5):352-61. PubMed ID: 19127078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.